Search Results
Anthracyclines for HER2-Positive Early Breast Cancer
Dr. Hurvitz on Eliminating Anthracyclines in HER2+ Breast Cancer Treatment
Update from KAITLIN for high-risk HER2-positive early breast cancer
Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani
Optimizing Therapy in HER2+ Disease with Dr. Hope S. Rugo
Optimizing treatment in patients with early-stage HER2-positive breast cancer
Adjuvant Therapy for Early-Stage HER2-Positive Breast Cancer
Investigating anthracycline, taxane and trastuzumab-based neoadjuvant chemotherapy in HER2+ eBC
HER2+ Early-Stage Breast Cancer: Peri-Operative Therapy
Extended adjuvant therapy for HER2-positive early breast cancer
Dr. Durand on Anthracyclines in Treatments for HER2+ Breast Cancer
Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit